Sugerencias en torno a medicamentos de efectividad demostrada sin interés comercial para la industria farmacéutica

Gac Med Mex. 2018;154(4):534-536. doi: 10.24875/GMM.17003670.

Abstract

Varios medicamentos de adecuada eficacia han sido retirados del mercado por razones financieras, ya sea por su reducido precio (la patente ha expirado) o porque han sido sustituidos por nuevos fármacos (con patentes vigentes); otros tantos no han sido desarrollados porque las enfermedades contra las que van dirigidos no son económicamente promisorias debido al tipo de población que las padece (estratos económicamente marginados o sin significación numérica). Deberán establecerse lineamientos e incentivos para la industria farmacéutica y de biotecnología.

Several drugs with adequate efficacy have been withdrawn from the market for financial reasons, either due to their reduced price (the patent has expired) or because they have been substituted with new drugs (with patents in force); many others have not been developed because the diseases they are directed against are not economically promising owing to the type of population that suffers from them (economically marginalized or numerically non-significant strata). Guidelines and incentives for the pharmaceutical and biotechnological industry should be established.

Keywords: Drug production; Drug research and development; Industria farmacéutica; Investigación y desarrollo de medicamentos; Pharmaceutical industry; Producción de fármacos.

MeSH terms

  • Cost-Benefit Analysis
  • Drug Approval / economics*
  • Drug Costs
  • Drug Industry / economics*
  • Humans
  • Patents as Topic
  • Pharmaceutical Preparations / economics*

Substances

  • Pharmaceutical Preparations